Search or ask a question

Does SIBO affect the blood microbiome?

Haemonchus contortus

Best insight from top research papers

Small Intestinal Bacterial Overgrowth (SIBO) primarily affects the gut microbiome rather than the blood microbiome. Research indicates that the blood microbiome can be stably retained in the bloodstream over time, even during conditions like sepsis . The gut microbiome, which includes Bacteroidetes as a major component, may show slight changes during sepsis development . However, the blood microbiome remains distinct from the gut microbiome, with specific taxonomic differences reflecting a tropism for the blood environment . While tools like StrainSifter can identify relatedness between blood-borne infections and the gut microbiome using genetic data , the blood microbiome itself appears to be resilient and separate from the effects of conditions like SIBO on the gut microbiome.

Answers from top 4 papers

PDF

Open Access

More filters

Papers (4)	Insight
Open access•Posted Content•DOI Functional genome and microbiome in blood of goats affected by the gastrointestinal pathogen Haemonchus contortus Yonathan Tilahun 10 Apr 2021-bioRxiv	Not addressed in the paper.
Book Chapter•DOI The Bacterial Blood Microbiota/Microbiome Eileen M. Burd, Lars F. Westblade - Show less +1 more 24 Aug 2017 2 Citations	Not addressed in the paper.
Open access•Posted Content•DOI Analysis of the blood microbiome in a porcine model of fecal-induced peritonitis Hwi Hyun, Min Seok Lee, Inwon Park, Hwa Soo Ko, Seungmin Yun, Dong-Hyun Jang, Seonghye Kim, Hajin Kim, Joo H. Kang, Jae Hyuk Lee, Taejoon Kwon - Show less +10 more 19 Feb 2021-bioRxiv	Not addressed in the paper.
Open access•Journal Article•DOI Analysis of Porcine Model of Fecal-Induced Peritonitis Reveals the Tropism of Blood Microbiome Hwi Hyun, Min Seok Lee, Inwon Park, Hwa Soo Ko, Seongmin Yun, Dong Hyun Jang, Seonghye Kim, Hajin Kim, Joo H. Kang, Jae Hyuk Lee, Taejoon Kwon - Show less +10 more 30 Aug 2021-Frontiers in Cellular and Infection Microbiology 5 Citations	Not addressed in the paper.

My columns

Related Questions

What is the relationship between sibo, CDTs and authoimmunity?5 answersSmall Intestinal Bacterial Overgrowth (SIBO) is linked to autoimmune conditions like chronic lymphocytic thyroiditis (Hashimoto thyroiditis) and differentiated thyroid cancer (DTC). Autoimmune thyroid diseases, characterized by antibodies like Thyroid Peroxidase (TPO) antibodies, are associated with SIBO and can lead to thyroid dysfunction. Moreover, the presence of Th17:Treg imbalances, indicative of chronic inflammatory conditions like type 2 diabetes, affects the gut microbiome and can be associated with dysglycemia. This highlights a complex interplay between SIBO, autoimmune thyroid diseases, chronic inflammatory conditions, and alterations in the gut microbiome. The relationship between SIBO, autoimmune thyroid diseases, and chronic inflammatory conditions underscores the intricate connections between the gut microbiota, immune responses, and the development of various health conditions.

What is the relationship between sibo, CDT (Cytolethal distending toxin) and autoimmunity?5 answersChronic exposure to Cytolethal Distending Toxin (CDT) has been associated with the activation of the DNA Damage Response and a strong type I interferon (IFN) response. CDT, produced by various pathogenic bacteria, induces DNA damage, chromosome fragmentation, and micronucleus formation during mitosis, leading to genetic instability. Moreover, CDT exposure has been linked to an inflammatory response, cell distention, and senescence. In the context of Small Intestinal Bacterial Overgrowth (SIBO), CDT exposure can lead to postinfectious effects like irritable bowel syndrome (IBS) and autoimmunity to vinculin. This suggests that CDT, through its genotoxic and immunomodulatory effects, may play a role in the development of autoimmunity in conditions like SIBO.

How are ibs and sibo related to one another?5 answersIBS and SIBO are closely related gastrointestinal disorders. SIBO, characterized by an overgrowth of bacteria in the small intestine, is considered a peripheral mechanism of IBS, particularly in diarrhea-predominant IBS (IBS-D). Studies show a higher prevalence of SIBO in IBS patients compared to healthy individuals, with rates ranging from 4% to 46% in IBS and 0% to 13% in controls. The dysbiosis in intestinal microbiota, including changes in microbial diversity and composition, plays a significant role in both disorders. Additionally, the eradication of SIBO through antibiotic therapy like rifaximin-α has shown improvements in IBS symptoms, indicating a potential pathogenic role of SIBO in IBS development. Further research is needed to explore the intricate interplay between SIBO and IBS for the development of optimal probiotic-based therapies.

Effect of SiO2 nano particles on bacteria?4 answersSiO2 nanoparticles have been found to have an inhibitory effect on the growth of bacteria. In one study, SiO2 nanoparticles were shown to inhibit the growth of Bacillus coagulans, a beneficial gut bacteria used as a probiotic. Another study demonstrated that SiO2 nanoparticles incorporated into polyvinyl chloride improved the antimicrobial properties of medical devices, including blood bags. Additionally, SiO2 nanoparticles functionalized with silver nanoparticles exhibited excellent antibacterial activity against Escherichia coli bacteria. Furthermore, ZnO@SiO2 nanoparticles based on rice husk were effective in removing Escherichia coli bacteria from water. Overall, these findings suggest that SiO2 nanoparticles can have both inhibitory and antibacterial effects on various types of bacteria.

Is SIBO associated with any gut inflammation?5 answersSIBO, or small intestinal bacterial overgrowth, is associated with gut inflammation. The presence of certain bacteria in the gut microbiota can lead to the production of inflammatory molecules, triggering inflammation in various body tissues. Inflammatory conditions of the gut, such as intestinal inflammation, can disrupt the integrity of the gut barrier and impair its function. Imbalances in mucosal levels of microflora-produced short-chain fatty acids have been linked to inflammatory conditions of the gut. These findings suggest that the composition of the gut microbiota and the presence of specific bacterial species can influence gut inflammation.

How does the microbiome alter the blood brain barrier?5 answersThe gut microbiome can alter the blood-brain barrier (BBB) by producing metabolites that interact with the BBB and affect its integrity and function. Methylamines, such as trimethylamine N-oxide (TMAO) and trimethylamine (TMA), derived from microbial metabolism of dietary choline and L-carnitine, have been shown to have contrasting effects on the BBB. Physiologically relevant concentrations of TMAO enhance BBB integrity and protect it from inflammatory insult, while TMA impairs BBB function and disrupts tight junction integrity. Long-term exposure to TMAO has also been found to have beneficial effects on cognition, improving visual recognition memory. Additionally, the gut microbiome composition, influenced by environmental factors such as the foster dam, can play a major role in BBB disruption, as seen in animal models of hypertensive cerebral small vessel disease. Furthermore, antibiotic-induced changes in gut microbial composition, particularly a decrease in acetic acid- and propionic acid-producing phyla and genera, have been associated with an increase in BBB permeability.

See what other people are reading

Is Desulfovibrio piger only present in the intestinal gut or also in the natural environment?

Desulfovibrio piger is not only found in the intestinal gut but also in the natural environment. Research has shown that Desulfovibrio species, including D. piger, are present in anaerobic environments like the human gut and can be isolated from fecal samples of both healthy individuals and patients with liver cirrhosis. Additionally, Desulfovibrio, particularly D. vulgaris strain L2, has been identified in swine manure, indicating its presence in environmental biotopes as well. Furthermore, Desulfovibrio spp., such as D. desulfuricans, have been associated with infections in humans, highlighting their presence in both the gastrointestinal tract and as opportunistic pathogens in various infections. Therefore, Desulfovibrio piger is not restricted to the intestinal gut but can also be found in environmental settings.Is Desulfovibrio piger exclusively present in the intestinal gut?

Desulfovibrio piger is not exclusively present in the intestinal gut. While it is identified as a common and abundant species within the Desulfovibrio genus in the human intestine, other Desulfovibrio species like D. desulfuricans and Cupidesulfovibrio oxamicus have also been isolated from fecal samples of healthy volunteers and patients with liver cirrhosis. Additionally, Desulfovibrio spp., including D. desulfuricans, can be found in various environments such as soil, water, and swine manure, contributing to H2S production. Therefore, Desulfovibrio species are not restricted to the intestinal gut and can be present in diverse ecological niches.Are there studies available which isolated D. piger from the environment?

Studies have indeed isolated Dolosigranulum pigrum (D. pigrum) from the environment. Research by Flores Ramos et al. identified D. pigrum strains in human nasal microbiota, highlighting its potential as a beneficial bacterium for therapeutic use. Additionally, Law et al. investigated the impact of different farrowing room disinfection practices on piglet microbiome colonization and found that environmental bacteria significantly influenced microbiome colonization in piglets, with distinct taxonomic compositions depending on the farrowing environment. These studies collectively demonstrate the presence of D. pigrum in environmental samples and emphasize the importance of understanding microbial exposures for both human and animal health.How do herbicide-resistant bacteria impact agricultural practices and ecosystems?

Herbicide-resistant bacteria play a significant role in agricultural practices and ecosystems. These bacteria, such as those isolated after herbicide use, can potentially aid in decontaminating herbicide-affected ecosystems. Moreover, the evolution of glyphosate-resistant bacteria showcases the adaptability of bacteria to anthropogenic substances, leading to the engineering of crops tolerant to herbicides. However, the widespread adoption of herbicide-resistant crops has contributed to biodiversity loss through various mechanisms, including the toxic effects of herbicides on non-target organisms and the development of herbicide-resistant weed species. This shift towards herbicide-resistant crops has also led to a reduction in crop rotation and increased reliance on herbicides, impacting agronomy and weed management practices negatively. Ultimately, the impact of herbicide-resistant bacteria on agricultural practices and ecosystems underscores the need for more environmentally friendly agricultural approaches to protect biodiversity.What is the relationship between ADHD and leaky gut syndrome?

ADHD and leaky gut syndrome exhibit a significant relationship, as indicated by various studies. Research suggests that intestinal permeability, reflected by gut leakage biomarkers like zonulin, occludin, and defensin, may be linked to ADHD susceptibility. Furthermore, dysbiosis in the gut mycobiome, particularly an increase in Candida species, and enhanced intestinal permeability have been associated with ADHD. Genome-scale metabolic models have identified specific gut microbiota indicators like Coprococcus, Collinsella, and Bacteroides, potentially linked to ADHD. Additionally, a two-sample Mendelian randomization analysis revealed a potential causal relationship between specific gut microbiota taxa and ADHD, highlighting the role of microbes like Eubacteriumhalliigroup and RuminococcaceaeUCG013 in ADHD risk. These findings collectively emphasize the intricate interplay between gut health, microbial composition, and ADHD development.How do polyphenols influence the risk factors for cardiovascular disease, such as blood pressure, cholesterol levels, and inflammation?

Polyphenols, abundant in fruits and vegetables, impact cardiovascular disease risk factors by targeting various mechanisms. They inhibit lipoprotein lipase (LPL) activity, potentially reducing lipid uptake into arteries. Polyphenols interact with gut microbiota, influencing chronic disease development, including cardiovascular issues. Through antioxidant properties, polyphenols combat oxidative stress, a key player in cardiovascular diseases. Moreover, polyphenols and their derivatives modulate gut dysbiosis, potentially preventing atherosclerosis and heart disease. To enhance bioavailability, nano-encapsulated polyphenols show promise in cardiovascular therapy, improving solubility and controlled release for better efficacy. Overall, polyphenols exhibit multifaceted effects on blood pressure, cholesterol levels, and inflammation, offering a holistic approach to cardiovascular disease prevention and management.Can manipulation of the environmental microbiome impact the health and function of the animal gut microbiome?

Manipulation of the environmental microbiome can indeed impact the health and function of the animal gut microbiome. Environmental stressors like pollution, parasites, and competition can alter the gut microbiome composition, leading to detrimental effects on the host's health, such as metabolic dysfunction and inflammation. In poultry, fluctuations in the microbiome due to environmental conditions can affect bird productivity and health, as the gut microbiome plays a crucial role in protecting against pathogens and aiding in nutrient production and immune system maturation. Additionally, selection for resilience in livestock can shift the gut microbiome composition, influencing inflammatory responses and metabolic processes, ultimately contributing to differences in animal resilience. Therefore, understanding and managing the environmental microbiome is essential for maintaining a healthy and functional animal gut microbiome.What is the composition of the bacterial microbiota of human skin?

The bacterial microbiota of human skin is diverse and primarily composed of Actinobacteriota, Firmicutes, Proteobacteria, and Bacteroidota phyla, with dominant genera like Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, and others. Factors influencing the skin microbiome include intrinsic characteristics like gender, age, and genetics, as well as external factors such as lifestyle, diet, hygiene, and environmental conditions. Skin microbiota play a crucial role in maintaining skin health and preventing diseases. Dysbiosis, or imbalance in the skin microbiome, can lead to various skin disorders like atopic dermatitis, acne, chronic wounds, psoriasis, and viral transmission. Understanding the interaction between the skin microbiota and human health can lead to novel therapeutic strategies utilizing skin bacteria.Does low NCOA4 levels induce ferroptosis in macrophages?

Low levels of NCOA4 have been associated with inducing ferroptosis in macrophages. Studies on lung adenocarcinoma and COPD emphysema have shown that decreased NCOA4 expression leads to increased ferroptosis in macrophages, particularly the M2 phenotype, contributing to the pathogenesis of these conditions. Additionally, in clear cell renal cell carcinoma (ccRCC), low NCOA4 expression is linked to enhanced ferroptosis and reduced infiltration of immune cells, including CD8+ T cells, which can impact disease progression and patient prognosis. Furthermore, research on sepsis has revealed that the interaction between STING and NCOA4 can trigger ferritinophagy-mediated ferroptosis in macrophages, exacerbating multiple organ injury during sepsis. Therefore, low NCOA4 levels indeed play a role in inducing ferroptosis in macrophages across various pathological conditions.Can probiotic therapy modulate the immune response and be beneficial in treating psoriasis in children?

Probiotic therapy has emerged as a promising adjuvant in the management of psoriasis, a chronic inflammatory skin condition, by modulating the immune response and potentially benefiting patients, including children. The World Health Organization defines probiotics as live microorganisms that confer health benefits to the host when administered in adequate amounts, which includes the regulation of both innate and adaptive immune responses, a mechanism that is crucial in the context of autoimmune diseases like psoriasis. Research has shown that specific probiotic strains can ameliorate psoriasis-like pathological characteristics in models by suppressing inflammatory cytokines related to the IL-23/T helper cell 17 (Th17) axis, which plays a significant role in the pathogenesis of psoriasis. Clinical trials have demonstrated that probiotics can lead to significant improvements in Psoriasis Area and Severity Index (PASI) scores, Dermatology Life Quality Index (DLQI), and inflammatory markers, indicating a reduction in disease activity and an enhancement in the quality of life for patients with psoriasis. These benefits are attributed to the stabilization of the gut bacterial community and the restoration of the gut microbiome's "signature," which in turn can lower the pH, produce bacteriocins, and improve gut barrier function. Furthermore, the modulation of the gut microbiome with probiotics has been linked to improved clinical outcomes, chronic inflammation, and cardiovascular risk factors in psoriasis patients. While the reviewed literature and clinical trials predominantly focus on adult populations, the underlying mechanisms through which probiotics exert their beneficial effects—such as immune modulation, restoration of gut microbiome balance, and reduction of inflammatory cytokines—are applicable to children with psoriasis. However, it is crucial to conduct further research specifically targeting pediatric populations to fully understand the efficacy and safety of probiotic therapy in children with psoriasis.What is the current state of metagenomic analysis in the field of microbiology?

Metagenomic analysis in microbiology has advanced significantly, enabling the study of microbial communities in diverse environments. This approach has revolutionized the understanding of microbial diversity and interactions, aiding research in various fields like agriculture, medicine, and industry. Metagenomics utilizes high-throughput sequencing technologies to decode genetic material from complex microbial populations, offering insights into community structures and functional potentials in an unbiased manner. Despite the progress, challenges persist in data analysis and interpretation, emphasizing the need for standardized bioinformatics processes. Metagenomic testing has been pivotal in diagnosing infectious diseases, showcasing both the power and limitations of this technique. Overall, metagenomic analysis continues to play a crucial role in uncovering novel enzymes, exploring human metagenomes, and paving the way for future research and industrial applications.